Piper Jaffray analyst Joshua E. Schimmer, MD reiterated an Overweight rating and $143 price target on Amgen (NASDAQ: AMGN) Friday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE